AEPCX
Price
$56.60
Change
-$0.40 (-0.70%)
Updated
Sep 20 closing price
CIGYX
Price
$11.24
Change
-$0.14 (-1.23%)
Updated
Sep 20 closing price
Ad is loading...

AEPCX vs CIGYX

Header iconAEPCX vs CIGYX Comparison
Open Charts AEPCX vs CIGYXBanner chart's image
American Funds Europacific Growth C
Price$56.60
Change-$0.40 (-0.70%)
VolumeN/A
CapitalizationN/A
AB Concentrated International Growth Adv
Price$11.24
Change-$0.14 (-1.23%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
AEPCX vs CIGYX Comparison Chart
Loading...
VS
AEPCX vs. CIGYX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and CIGYX is a StrongBuy.

FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 139B vs. CIGYX (174M). AEPCX pays higher dividends than CIGYX: AEPCX (0.81) vs CIGYX (0.00). AEPCX was incepted earlier than CIGYX: AEPCX (24 years) vs CIGYX (9 years). AEPCX (34.00) and CIGYX (33.00) have comparable annual turnover. CIGYX has a lower initial minimum investment than AEPCX: CIGYX (0) vs AEPCX (250). AEPCX annual gain was more profitable for investors over the last year : 11.49 vs. CIGYX (10.14). AEPCX return over 5 years is better than : 11.66 vs. CIGYX (-0.26).
AEPCXCIGYXAEPCX / CIGYX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years9 years-
Gain YTD6.2295.323117%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets139B174M79,885%
Annual Yield % from dividends0.810.00-
Returns for 1 year11.4910.14113%
Returns for 3 years-17.79-29.9259%
Returns for 5 years11.66-0.26-4,486%
Returns for 10 years17.76N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LANV1.770.09
+5.36%
Lanvin Group Holdings Limited
DLTR75.672.17
+2.95%
Dollar Tree
HGTY11.12-0.02
-0.18%
Hagerty
MQ5.04-0.02
-0.40%
Marqeta
BGLC0.42-0.02
-3.46%
BioNexus Gene Lab Corp